exagen.com (XGN) Net Margin

Graphic logo of Exagen (XGN)

Exagen Inc. management is currently optimizing its business model to minimize losses. The company is developing patent-protected AI tests deeply integrated into US rheumatology. Aggregate profit margins on GURU.Markets demonstrate the efficiency of laboratory centers utilizing unique biomarkers, while the -25.10 level reflects the current magnitude of this metric, determining the portion of revenue converted into actual income.

XGN: exagen.com Net Profit Rate 07/04/2022 - 11/20/2026

Comprehensive metric breakdowns and analytics for exagen.com (XGN)

- share price and expert price forecast:
- market capitalization details:
Basic company analysis:Exagen, XGN
Manufactured product of Exagen Inc.

This indicator is calculated as the ratio of net income to revenue, determining the efficiency of converting every dollar of sales into actual shareholder income. By analyzing the net profit margin, an investor can see how the centralization of laboratory tests at Exagen Inc. (XGN) reduces operating expenses during scaling, which directly reflects the resilience of the business model on this chart.